In addition, cells treated with a concentration of 2.5 ng/mL of gold nanoparticles demonstrated degradation of GAPDH (glyceraldehyde-3-phosphate dehydrogenase), which is known to be over-expressed in cancer (Mishra et al., 2016). This evidence concerns the gene GAPDH and cancer.